Mutation at ser32 of I kappa B alpha blocks NF-kappa B activation.
Chen
C G
CG
Immunology Research Centre, St. Vincent's Hospital, Melbourne, Victoria, Australia.
Malliaros
J
J
Katerelos
M
M
d'Apice
A J
AJ
Pearse
M J
MJ
D016475:3T3 Cells; D000595:Amino Acid Sequence; D000818:Animals; D002460:Cell Line; D002522:Chlorocebus aethiops; D004268:DNA-Binding Proteins / Q000096:biosynthesis / Q000378:metabolism*; D020672:I-kappa B Proteins; D008156:Luciferases / Q000096:biosynthesis; D051379:Mice; D016297:Mutagenesis, Site-Directed; D000072000:NF-KappaB Inhibitor alpha; D016328:NF-kappa B / Q000037:antagonists & inhibitors*; D017354:Point Mutation; D011401:Promoter Regions, Genetic; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000378:metabolism; D012694:Serine; D014162:Transfection
D004268:DNA-Binding Proteins; D020672:I-kappa B Proteins; D016328:NF-kappa B; C000606205:Nfkbia protein, mouse; D011994:Recombinant Proteins; D000072000:NF-KappaB Inhibitor alpha; D012694:Serine; D008156:Luciferases